While these mechanisms require validation in TC, our findings that GRK5 inhibition (i) enhances APC-mediated immune responses (Supplementary Figure S4) and (ii) synergizes with T-cell cytotoxicity (Figure 6C) position it as a master regulator of tumor-immune crosstalk. Here, GRK5 is linked to neoplasm.